Skip to search.
 TSX Up0.08% TSX Ventures 0.00%

AstraZeneca PLC (AZN)

-NYQ

52.35 May 22, 4:02PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Net Income 6,327,000   10,016,000   8,081,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,518,000  2,550,000  2,741,000  
Adjustments To Net Income6,000  (1,652,000)54,000  
Changes In Accounts Receivables755,000  (1,108,000)10,000  
Changes In Liabilities(3,899,000)(4,080,000)(3,190,000)
Changes In Inventories(150,000)(256,000)88,000  
Changes In Other Operating Activities -   -   -  
Total Cash Flow From Operating Activities 6,948,000   7,821,000   10,680,000  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(672,000)(839,000)(791,000)
Investments3,741,000  (827,000)10,000  
Other Cash flows from Investing Activities(4,928,000)(356,000)(1,445,000)
Total Cash Flows From Investing Activities (1,859,000) (2,022,000) (2,226,000)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(3,665,000)(3,764,000)(3,361,000)
Sale Purchase of Stock(2,206,000)(5,606,000)(2,110,000)
Net Borrowings900,000  46,000  (1,749,000)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities (4,923,000) (9,321,000) (7,334,000)
Effect Of Exchange Rate Changes(4,000)(25,000)33,000  
Change In Cash and Cash Equivalents 166,000   (3,522,000) 1,120,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.